MAN & SCIENCE

Active

Public limited companyfounded 201115 yrs activeBoulevard de Patience et Beaujonc 3, 4000 Liège, BelgiumKBO/BCE: BE 0837.403.770

Summary

The annual accounts of MAN & SCIENCE for fiscal year 2025 show a net loss of 62% of total assets and of 58% of the equity at the start of that year. The 2025 annual accounts show equity of €2.44M and a net result of €-3.34M. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 45% of 117 sector peers (fiscal year 2025). The company has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.3% (very low).

Watch Print / PDF

Checked score

Score 2025

55 / 100

Fair

The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.

Axes · tick = 2024

Profitability0=

Solvency70▼-30

Growth52=

Track record100

Bankruptcy probability, 12 months

0.3% Very low

0%0.5%1.5%4%10%≥ 25%

Credit up to €130k at 30 days only on tighter terms

Net loss of at least half of total assets or of the equity at the start of the financial year.

Liquidity short (current ratio 0.59 against 4.11 in 2024; short-term debt: 42.1% and cash: 20% of total assets), and 54.8% of the assets are financed with debt.

How do we compute the score and the probability?

Credit check for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Lower-failure-rate sector

In this sector companies fail less often than the Belgian average.

Gazette · bankruptcies per sector, NACE 32

Relative position

BE, all sectors

reference

Sector 32

lower

← fewer bankruptcies more bankruptcies →

Lower-risk legal form

Companies with this legal form statistically fail less often than a BV.

KBO · legal form

Long track record

A company with a long track record statistically fails less often than a young one.

KBO · incorporation date

Age against the risk zone

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Persistent losses

Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.

NBB · annual accounts 2025

Net result per financial year

1819202122232425

2018 to 2025 · latest year €-3.34M

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

31 d early

2024

71 d late

2023

184 d late

2022

31 d late

2021

86 d early

2020

50 d early

2019

on the day

← before the deadline after the deadline →

Checked, nothing found (2)

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

Companies Code · seven months

Position in the running window

24-09-2026 today31-12-2026 close31-07-2027 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials · fiscal year 2025, full schema

Turnover

Not included in this filing

EBIT margin

Not included in this filing

Net result

€-3.34M▲ 73.8%

2024 · €-12.72M

2018: €-21k 2019: €-637 2020: €-383k 2021: €-199k 2022: €-4.20M 2023: €476k 2024: €-12.72M

2018 → 2025

Working capital

€-927k

2024 · €4.17M

2018: €-286k 2019: €-325k 2020: €2.74M 2021: €1.92M 2022: €4.11M 2023: €2.84M 2024: €4.17M

2018 → 2025

Multi-year overview

Every figure with its change against the year before

▲ rise ▼ fall

Line20212022202320242025Trend

Equity€1.96M-€12.77M▲ 553%€13.25M▲ 3.7%€5.78M▼ 56.4%€2.44M▼ 57.8%

Operating result€-318k-€-4.19M▼ 1,217%€441k€-3.26M€-3.67M▼ 12.5%

Net result€-199k-€-4.20M▼ 2,008%€476k€-12.72M€-3.34M▲ 73.8%

Result per fiscal year

Operating resultNet result

The operating result stays negative: a loss of €3.67M in 2025 against €3.26M in 2024; the loss grows.

Balance-sheet composition

2025 in colour, 2024 as the grey bar beneath

Assets €5.39M

75.1%

24.9%

Fixed assets €4.05M ▲ 92.4%

Current assets €1.34M ▼ 75.7%

Equity and liabilities €5.39M

45.2%

54.8%

Equity €2.44M ▼ 57.8%

Debt €2.95M ▲ 60.2%

Debt's share of the balance-sheet total rises from 24.2% to 54.8%. Equity is lower and debt is higher.

Key figures and ratios

2025 value · change against 2024

EBITDA

€-3.13M▼

2024 · €-2.97M

Cash flow

€-2.80M▲

2024 · €-12.44M

Current ratio

0.59▼

2024 · 4.11

Debt to equity

1.21▲

2024 · 0.32

ROE

-136.9%▲

2024 · -220.3%

ROA

-61.9%▲

2024 · -167.0%

Interest coverage

-30.05▲

2024 · -30.37

Debt ≤ 1 year

€2.27M▲

2024 · €1.34M

Debt > 1 year

€685k▲

2024 · €500k

Income taxes

€5k▲

2024 · €2k

Staff costs

€931k▲

2024 · €780k

Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Filed annual accounts As filed with the NBB · 2025 against 2024 · 48 lines

Balance sheet Code20242025

Assets

Total assets20/58€7.62M€5.39M▼

Fixed assets21/28€2.11M€4.05M▲

Intangible fixed assets21€1.98M€3.94M▲

Tangible fixed assets22/27€120k€101k▼

Plant, machinery and equipment23€4k€6k▲

Furniture and vehicles24€116k€95k▼

Financial fixed assets28€5k€5k=

Current assets29/58€5.51M€1.34M▼

Amounts receivable within one year40/41€342k€247k▼

Trade receivables40€153k€36k▼

Other amounts receivable41€189k€211k▲

Cash at bank and in hand54/58€5.17M€1.08M▼

Deferred charges and accrued income490/1€4k€17k▲

Equity and liabilities

Total equity and liabilities10/49€7.62M€5.39M▼

Equity10/15€5.78M€2.44M▼

Contributions10/11€22.88M€22.88M=

Capital10€22.88M€22.88M=

Issued capital100€22.88M€22.88M=

Profit (loss) carried forward14€-17.10M€-20.44M▼

Amounts payable17/49€1.84M€2.95M▲

Amounts payable after more than one year17€500k€685k▲

Financial debts170/4€500k€685k▲

Amounts payable within one year42/48€1.34M€2.27M▲

Current portion of amounts payable after more than one year42€300k€71k▼

Trade debts44€915k€1.08M▲

Suppliers440/4€915k€1.08M▲

Taxes, remuneration and social security45€126k€118k▼

Taxes450/3€4k€90▼

Remuneration and social security454/9€122k€118k▼

Other amounts payable47/48€2k€1.00M▲

Income statement Code20242025

Remuneration, social security and pensions62€780k€931k▲

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€283k€534k▲

Other operating charges640/8-€2k

Gross operating margin9900€-2.19M€-2.20M▼

Operating profit (loss)9901€-3.26M€-3.67M▼

Financial income75/76B€49k€438k▲

Recurring financial income75€49k€69k▲

Non-recurring financial income76B-€369k

Financial charges65/66B€9.51M€104k▼

Recurring financial charges65€98k€104k▲

Non-recurring financial charges66B€9.41M-

Profit (loss) for the period before taxes9903€-12.72M€-3.33M▲

Income taxes67/77€2k€5k▲

Profit (loss) for the period9904€-12.72M€-3.34M▲

Profit (loss) for the period to be appropriated9905€-12.72M€-3.34M▲

Appropriation of the result

Profit (loss) to be appropriated9906€-17.10M€-20.44M▼

Profit (loss) brought forward from the previous period14P€-4.38M€-17.10M▼

Social balance

Average headcount (FTE)90875.87.6▲

The notes to these accounts (17 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

All 33Financial 5Gazette 18Filings 10

Next filing, fiscal year 2026, expected by 31-07-2027

2026

30-06

NBB filing Annual accounts filed

fiscal year 2025 · full schema

11-03

State Gazette act Capital & shares

Capital increase · Capital · Bank account8 facts ▸

General meeting, 19-02-2026
Capital increase, €5.286.737,75
Capital increase, €778.426,25
Capital, €28.945.572,81
Bank account, ING
Power of attorney, Administrateurs de MAN & SCIENCE
Power of attorney, Sibylle FALLA
Waiver, renonciation au droit de souscription préférentielle par les autres actionnaires

2025

10-10

NBB filing Annual accounts filed

fiscal year 2024 · full schema · 71 days late

06-10

State Gazette act Resignations: NOSHAQ PARTNERS SRL, Olivier Taelman and 2 others

Appointments: SPARAXIS SA (director) and BIOTECH MANAGEMENT & CONSULTING SRL (day-to-day manager) · Permanent representatives: Géry Lefebvre and Hugues Wallemacq · Reappointments: Robert Taub, Jürgen Hambrecht and Anneliese Monden21 facts ▸

General meeting, 25-07-2025
Director resignation, NOSHAQ PARTNERS SRL (director)
Director discharge, NOSHAQ PARTNERS SRL
Director appointment, SPARAXIS SA (director)
Permanent representative, Géry Lefebvre
Mandate compensation, SPARAXIS SA
Director reappointment, Robert Taub (director)
Director reappointment, Jürgen Hambrecht (director)
Director reappointment, Anneliese Monden (director)
Director resignation, Olivier Taelman (director)
Board composition, Robert Taub (director)
Board composition, Jürgen Hambrecht (director)
+9 further facts in this act

31-01

NBB filing Annual accounts filed

fiscal year 2023 · micro schema · 184 days late

2024

31-12

Financial Weakest financial yearnet €-12.72M ▼2773%

Net result drops to €-12.72M, the lowest in the series; recovery starts the following year.

31-12

State Gazette act Capital & shares

Capital increase · Bank account · Share issue10 facts ▸

General meeting, 26/12/2024
Capital increase, €4.531.701,99
Bank account, ING
Capital increase, €718.298,01
Share issue, warrants, 36800
Capital, €22.880.772,81
Statutes amendment
Power of attorney, MAN & SCIENCE
Waiver of preemptive right, Renonciation par les actionnaires à leur droit de préférence de souscrire aux nouveaux Warrants en faveur de la société, qui ne pourra pas exercer elle-même ces…
Capital increase

14-11

State Gazette act Appointment: Olivier Ménage (ceo)

Permanent representative: Olivier Ménage · Power of attorney6 facts ▸

Board meeting, 24-07-2024
Power of attorney, OCTAVIAN SRL
Director appointment, Olivier Ménage (ceo)
Permanent representative, Olivier Ménage
Power of attorney, Olivier Ménage
Power of attorney, Olivier Ménage

16-05

State Gazette act Appointment: Olivier TAELMAN (director)

Resignation: Lars LUND-ROLAND (director) · Power of attorney · Registered-office move8 facts ▸

Board meeting, 13-06-2023
Power of attorney, Fabian SUAREZ
Power of attorney, Fausto Remedia
Board meeting, 31-08-2023
Director appointment, Olivier TAELMAN (director)
Director resignation, Lars LUND-ROLAND (director)
Board meeting, 28-03-2024
Registered-office move, Boulevard de Patience et Beaujonc 3 boîte 24, 4000 Liège

2023

31-12

Financial Back to profitnet €476k

Net result €476k after 5 loss-making years.

31-08

NBB filing Annual accounts filed

fiscal year 2022 · micro schema · 31 days late

23-02

State Gazette act Capital & shares · Statutes amendment

Capital increase · Capital · Statutes amendment7 facts ▸

General meeting, 20-12-2022
Capital increase, €2.855.768,63
Capital increase, €4.510.425,18
Capital, €17.630.772,81
Statutes amendment
Power of attorney, CLEENEWERCK de CRAYENCOUR Dimitri
Power of attorney, SUAREZ GONZALEZ Fabian

Show earlier events

2022

31-12

Financial Equity above €10MEq €12.77M ▲553%

Equity rises from €1.96M to €12.77M.

25-08

State Gazette act Resignations & appointments

Power of attorney2 facts ▸

Board meeting, 27-06-2022
Power of attorney, Président du Conseil d'administration, CEO ou Finance Manager

30-05

State Gazette act Appointments: Robert TAUB, Jürgen HAMBRECHT and 3 others

Permanent representative: Hugues WALLEMACQ · Capital · Capital increase16 facts ▸

General meeting, 20-05-2022
Capital, €10.264.579
Capital increase, €7.647.723
Share issue, subscription rights, 11228
Statutes amendment
Director appointment, Robert TAUB (director)
Director appointment, Jürgen HAMBRECHT (director)
Director appointment, NOSHAQ PARTNERS (director)
Permanent representative, Hugues WALLEMACQ
Director appointment, Anneliese MONDEN (director)
Director appointment, Lars LUND-ROLAND (director)
Mandate compensation, Robert TAUB
+4 further facts in this act

06-05

NBB filing Annual accounts filed

fiscal year 2021 · micro schema

09-03

State Gazette act Permanent representative: Fabian Suarez

Power of attorney · Mandate effective date · Mandate term6 facts ▸

Board meeting, 14-12-2021
Power of attorney, ActuaRisk Consulting
Permanent representative, Fabian Suarez
Power of attorney, ActuaRisk Consulting
Mandate effective date, 01-01-2022
Mandate term, durée illimitée

2021

11-06

NBB filing Annual accounts filed

fiscal year 2020 · micro schema

12-05

State Gazette act Resignation: Marc Foidart (permanent representative)

Appointment: Hugues Wallemacq (permanent representative) · Mandate compensation · Power of attorney9 facts ▸

General meeting, 02-04-2021
Director resignation, Marc Foidart (permanent representative)
Director appointment, Hugues Wallemacq (permanent representative)
Mandate compensation, Hugues Wallemacq
Board composition, Robert Taub (director)
Board composition, Jürgen Hambrecht (director)
Board composition, Anneliese Monden (director)
Board composition, Noshaq Partners SC (director)
Power of attorney, Philip Mackenzie Hartog

24-02

State Gazette act Appointment: Anneliese Monden (director)

Permanent representative: Marc Foidart · Mandate compensation · Registered-office move9 facts ▸

General meeting, 26-01-2021
Director appointment, Anneliese Monden (director)
Mandate compensation, Anneliese Monden
Board composition, Robert Taub (director)
Board composition, Jürgen Hambrecht (director)
Board composition, Anneliese Monden (director)
Board composition, Noshaq Partners SC (director)
Permanent representative, Marc Foidart
Registered-office move, Rue du Fond Cattelain. 2, 1435 Mont-Saint-Guibert

2020

31-12

Financial Liquidity times 225current ratio 96.18

Current ratio from 0.43 to 96.18; short-term debt falls from €568k to €29k.

31-12

Financial Equity above €2MEq €2.15M

Equity rises from €-18k to €2.15M.

29-09

State Gazette act Resignation: Anneliese Monden (director)

Appointments: NOSHAQ PARTNERS (director) and Robert TAUB (chair) · Permanent representative: Marc Foidart · Reappointments: Robert TAUB (director) and Jürgen HAMBRECHT (director)15 facts ▸

General meeting, 15-09-2020
Capital increase, €560.400
Capital increase, €155.172
Capital increase, €1.839.284
Capital, €2.616.856
Share issue, droits de souscription, 71
Statutes amendment
Director resignation, Anneliese Monden (director)
Director appointment, NOSHAQ PARTNERS (director)
Permanent representative, Marc Foidart
Director reappointment, Robert TAUB (director)
Director reappointment, Jürgen HAMBRECHT (director)
+3 further facts in this act

31-07

NBB filing Annual accounts filed

fiscal year 2019 · full schema

04-06

State Gazette act Registered office

Registered-office move2 facts ▸

Board meeting, 05-02-2020
Registered-office move, 9 rue Emile Francqui à 1435 Mont-saint-Guibert

2019

31-10

NBB filing Annual accounts filed

fiscal year 2018 · micro schema · 92 days late

08-01

State Gazette act Capital & shares · Resignations & appointments · Restructuring

Merger · Dissolution · Name change9 facts ▸

General meeting, 19-12-2018
Merger, 19-12-2018
Merger, 19-12-2018
Dissolution, 19-12-2018
Dissolution, 19-12-2018
Name change, MAN & SCIENCE
Power of attorney, DEPRINCE, CHERPION & Associés
Merger project, 03-09-2018
No share attribution, toutes les actions des sociétés absorbées étant détenues par la société absorbante

2018

17-09

State Gazette act Restructuring

Merger · Accounting effect3 facts ▸

Merger
Merger
Accounting effect, 31-07-2018

31-08

NBB filing Annual accounts filed

fiscal year 2017 · micro schema · 31 days late

2017

31-07

NBB filing Annual accounts filed

fiscal year 2016 · micro schema

07-02

State Gazette act Registered office

Registered-office move2 facts ▸

Board meeting, 01-12-2016
Registered-office move, Avenue Blücher 63 -1180 Bruxelles

2016

20-06

State Gazette act Reappointments: Robert TAUB (director) and Uwe WASCHER (director)

Resignation: MASHIACH ADI (director)4 facts ▸

General meeting, 02-06-2014
Director reappointment, Robert TAUB (director)
Director reappointment, Uwe WASCHER (director)
Director resignation, MASHIACH ADI (director)

2011

01-07

State Gazette act Incorporation

Appointments: Robert TAUB, Uwe Siegfried WASCHER and ADI MASHIACH · Founding capital · Bank account12 facts ▸

Incorporation, 28-06-2011
Founding capital, €62.000
Bank account, CBC Banque SA
Director appointment, Robert TAUB (director)
Director appointment, Uwe Siegfried WASCHER (director)
Director appointment, ADI MASHIACH (director)
Mandate compensation, Robert TAUB
Mandate compensation, Uwe Siegfried WASCHER
Mandate compensation, ADI MASHIACH
Power of attorney, Fausto Remedia
Founder, Robert TAUB
Founder, Uwe Siegfried WASCHER

Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors

9 directors, no change since 2025

Biotech Management & Consulting

Day-to-day manager · since 25-07-2025 · Private limited company · perm. rep.: Hugues Wallemacq

Current

SPARAXIS

Director · since 01-07-2025 · Public limited company · perm. rep.: Géry Lefebvre

Current

Olivier Ménage

Ceo · since 02-07-2024

Current

NOSHAQ PARTNERS

Director · since 20-05-2022 · Legal entity · perm. rep.: Hugues WALLEMACQ

Current

Anneliese Monden

Director · since 16-12-2020

Current

Jürgen Hambrecht

Director · since 15-09-2020

Current

3 other directors

Robert Taub

Director · since 28-06-2011

Current

Uwe WASCHER

Director

Not recently confirmed

Uwe Siegfried WASCHER

Director · since 28-06-2011

Not recently confirmed

25-07-2025 Biotech Management & Consulting: Appointed as Day-to-day manager

25-07-2025 NOSHAQ PARTNERS: Resigned as Director

25-07-2025 OCTAVIAN: Resigned as Day-to-day manager

01-07-2025 SPARAXIS: Appointed as Director

20-05-2025 Anneliese Monden: Mandate renewed as Director

Full history in the Timeline (29 changes) →

Location & real-estate footprint

Registered office, Liège · 1 establishment unit since 2011

establishment The establishment unit on the map

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Boulevard de Patience et Beaujonc 34000 Liège

Ground area

1.9 ha

Parcel 62042B0366/00B003, Wallonia. Linked by address, not a title deed.

1 establishment unit

MAN & SCIENCE

Boulevard de Patience et Beaujonc 3, 4000 LiègeManufacture of computer, electronic and optical products

since 20112.201.080.646

1 parcel

Wallonia 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
62042B0366/00B003	Wallonia	1.9 ha	-	-

Linked by address, not proof of ownership

Methodology

via registered seat: 1

1 of 1 parcel with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Articles of association

Purpose

La recherche et le développement, la fabrication et la vente d’équipements médicaux

according to the deed of 29-09-2020

Structure & network

Connections & network

32 connected companies

Shared directorsBundled connections

Linked via shared directors

Biotech Management & Consulting

via Hugues Wallemacq · Permanent representative

→

ADVANCED MECHANICAL AND OPTICAL SYSTEMS

Shared corporate director

→

AEROSPACELAB

Shared corporate director

→

AMPACIMON

Shared corporate director

→

Show 28 more companies with a shared director

ANATIS

Shared corporate director

→

AQUATIC SCIENCE

Shared corporate director

→

CAPITANE COOP

Shared corporate director

→

ECOSTAL GROUP

Shared corporate director

→

EPIMEDE

Shared corporate director

→

GALLER BOUTIQUES

Shared corporate director

→

GALLER HOLDING

Shared corporate director

→

GAMBIT Financial Solutions

Shared corporate director

→

ID CAMPUS ASBL

Shared corporate director

→

IGNITY

Shared corporate director

→

JD'C INNOVATION

Shared corporate director

→

LA CHOCOLATERIE GALLER

Shared corporate director

→

LEANSQUARE

Shared corporate director

→

LIFEPOWR

Shared corporate director

→

NOMICS

Shared corporate director

→

NOSHAQ IMMO

Shared corporate director

→

NOSHAQ SPIN-OFFS

Shared corporate director

→

NOSHAQ VENTURE

Shared corporate director

→

NSI IT Software & Services

Shared corporate director

→

ONCORADIOMICS

Shared corporate director

→

PROTECTION UNIT GROUP

Shared corporate director

→

Schaeffler Aerosint

Shared corporate director

→

Société d'Investissement du Bassin liégeois

Shared corporate director

→

superdog

Shared corporate director

→

TEMPORA

Shared corporate director

→

TRASIS

Shared corporate director

→

WIDETECH

Shared corporate director

→

Wishbone

Shared corporate director

→

Acquisitions and mergers

2 transactions

Took over:MAN & SCIENCE

BE 0837.403.572State Gazette act of 08-01-2019 (2 acts) · effective 19-12-2018

Took over:SURGICAL ELECTRONICS

BE 0837.403.671State Gazette act of 08-01-2019 (2 acts) · effective 19-12-2018

Capital and shareholders

Shareholders according to the acts

After 2 capital increases act of 11-03-2026 ↗

ROBELGA (BE 0894.734.532) 50,573 shares · 2,354,979.92 EUR
JH Capital GmbH 24,639 shares · 1,147,344.62 EUR

After 2 capital increases act of 23-02-2023 ↗

BMI ESTATE 26,753 shares · 1,612,877.16 EUR
TOGETHER 11,040 shares · 665,576.34 EUR
JH Capital GmbH 16,071 shares · 968,883.83 EUR
SUAREZ GONZALEZ Fabian 7,604 shares · 458,427.76 EUR
NOSHAQ SPIN-OFFS 24,142 shares · 1,455,465.94 EUR
Société Régionale d'Investissement de Wallonie (BE 0219.919.487) 18,328 shares · 1,104,953.19 EUR
AUFF S.A. (BE 0794.845.813) 8,294 shares · 500,026.28 EUR
RUDOLF FUCHS KAPITALANLAGEGESELLSCHAFT MBH (BE 0794.846.605) 6,635 shares · 400,008.97 EUR
CARONI Milo 3,317 shares · 199,974.34 EUR

After the capital increase act of 30-05-2022 ↗

TRONVIK CONSULTING AS 17,160 shares
BRATBAK CONSULTING AS 17,160 shares
ELAR CONSULTING AS 3,006 shares
STARTPARTNER AS 1,544 shares
BMI ESTATE (BE 0725.424.693) 72,605 shares
David DODICK 1,544 shares
Olivier TAELMAN 2,607 shares

After 3 capital increases act of 29-09-2020 ↗

Robert TAUB 69 shares
Jürgen HAMBRECHT 70 shares
TOGETHER 70 shares
NOSHAQ SPIN-OFFS (BE 0465.001.172) 134 shares

At incorporation act of 01-07-2011 ↗

Robert TAUB founder
Uwe Siegfried WASCHER founder

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years

11-03-2026 Capital increase of 5,286,737.75 EUR · to 28,167,146.56 EUR · 130,241 new shares
11-03-2026 Capital increase of 778,426.25 EUR · to 28,945,572.81 EUR · no new shares
31-12-2024 Capital increase of 4,531,701.99 EUR · to 22,162,474.80 EUR · 115,267 new shares
31-12-2024 Capital increase of 718,298.01 EUR · to 22,880,772.81 EUR · from reserves
23-02-2023 Capital increase of 2,855,768.63 EUR · to 13,120,347.63 EUR · 47,369 new shares
23-02-2023 Capital increase of 4,510,425.18 EUR · to 17,630,772.81 EUR · 74,815 new shares
30-05-2022 Capital increase of 7,647,723 EUR · to 10,264,579 EUR · 115,626 new shares
29-09-2020 Capital increase of 560,400 EUR · to 622,400 EUR · 75 new shares

Show 3 older capital entries

29-09-2020 Capital increase of 155,172 EUR · to 777,572 EUR · 268 new shares
29-09-2020 Capital increase of 1,839,284 EUR · to 2,616,856 EUR · no new shares · from reserves
01-07-2011 Incorporation · 62,000 EUR · 1,000 shares

Recognitions · licences · registrations

Legal Entity Identifier

254900DPZO5P0HQ6WZ50

live in the LEI register

Similar companies · same sector, comparable size

Of 1,249 companies in sector 32500 we hold annual accounts for 694. 294 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification

Legal formPublic limited company

Founded29-06-2011

Fiscal year end31-12

Activities, NACEBEL 2025

32500Manufacture of medical and dental instruments and supplies

86995Nutrition and dietetics services

46460Wholesale of pharmaceutical and medical goods

47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses

Sources

Crossroads Bank for EnterprisesNational Bank · 14 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.